Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Ultimately, AI adoption is shaped less by enthusiasm or technical feasibility and more by whether organizations can prove ...

The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. | The FDA's newest draft guidance reinforces its previous commitment to streamlining biosimilar drug ...

The VI-Grade DiM500 system at Bridgestone's Rome facility enables virtual tire testing before physical prototypes are ...